http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101359943-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
| filingDate | 2005-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101359943-B1 |
| titleOfInvention | Vaccines against HPP 16 and HPP 18 and at least another HPP type selected from HPP 31, 45 or 52 |
| abstract | The present invention relates to immunogenic compositions comprising VLPs from HPV 16 and 18 and VLPs from one or more other HPV cancer types selected from the group consisting of HPV 31, 45 and 52 and methods of making such compositions. , Wherein the dose of VLPs of one or more other cancer types is reduced compared to the dose of VLPs of HPV 16 or 18. |
| priorityDate | 2004-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.